CNS Vital Signs
CNS Vital Signs is a world leader in the design and development of neurocognitive and behavioral assessment tools and technologies. We provide clinicians and researchers with leading-edge technologies for improved neurocognitive and behavioral evaluation and management capabilities. Our platform offers broad-spectrum computerized neurocognitive testing to measure, monitor, and manage neurocognitive and behavioral health. Clinicians use CNS Vital Signs as a brief-core assessment to get a rapid or immediate read on a patient's neurocognitive status. The assessment platform is a well-established, commonly reimbursed method for evaluating patients who demonstrate neurocognitive or behavioral symptoms. CNS Vital Signs has been used for testing neurocognitive function by over 10,000 clinicians and researchers in 52 countries. Our platform provides solutions for hospitals, clinicians, and researchers to measure, monitor, and manage conditions.
Learn more
CogniFit
CogniFit is a leading provider of personalized online cognitive training programs designed to assess and enhance various cognitive skills across all age groups. Their scientifically validated platform offers over 60 engaging games and mental tasks that target areas such as memory, concentration, reasoning, and coordination. Users can begin with a free initial evaluation to understand their cognitive profile and then engage in tailored training programs to strengthen specific cognitive abilities. CogniFit's tools are utilized by individuals seeking to improve their cognitive functions, as well as by professionals in healthcare, education, and research settings to support cognitive development and rehabilitation. Monitor your daily and weekly cognitive score stats. Set a goal for yourself to increase the score through multiple brain training sessions. Develop a plan of action to train and practice as often as you'd like.
Learn more
MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
Cognistat Assessment System
Cognistat is the leading cognitive test for assessing the five major cognitive ability areas: language, spatial skills, memory, calculations and reasoning. Cognistat was developed at Stanford University and is standardized for adolescents, adults and seniors (60 – 84). It can be administered by any suitably trained healthcare professional. The Cognistat assessment and screening test has been culturally adapted with clinical validity in many languages by collaborating with important universities, academic institutions and customers worldwide. With over 400 peer-reviewed scientific articles, Cognistat’s use in patients with stroke, dementia, traumatic brain injury, major psychiatric disorders and substance abuse is well documented. The Cognistat Assessment System preserves the strengths of the highly regarded paper and pencil version of Cognistat: Assesses five major areas of cognitive functioning, gives a quick yet comprehensive evaluation, utilizes a screen and metric approach.
Learn more
